Funding programme

Horizon Europe is the EU’s key funding programme for research and innovation. Read more about the Horizon Europe programme here.

‍

Call overview

This call aims to support the development and/or use tools and strategies that address critical areas of biomedical research where animal-models are currently used but are of limited translational value.

‍

Call detail

This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 5 “Unlocking the full potential of new tools, technologies and digital solutions for a healthy society”. To that end, proposals under this topic should aim for delivering results that are directed towards and contributing to several of the following Expected Outcomes:

• Researchers utilise tools and strategies that are more relevant to the human situation as compared to the currently used animal models.
• Fewer live animals are used in biomedical research.
• Health technology developers will get access to improved human-relevant tools or strategies allowing for a faster pace of innovation.
• Legislators and regulators will benefit from strengthened EU leadership in non-animal based biomedical research that is socially accepted and sustainable.
• Healthcare providers and patients will benefit from innovative tools or strategies opening up novel biomedical concepts enabling improved disease prediction, prevention and treatment.

‍

Eligibility

To be eligible for funding, applicants must be established in one of the following countries:

• the Member States of the European Union, including their outermost regions;
• the Overseas Countries and Territories (OCTs) linked to the Member States;
• countries associated to Horizon Europe;
• low- and middle-income countries

See the full list in the General Annexes.

The following exceptions apply:

In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.

The Joint Research Centre (JRC) may participate as member of the consortium selected for funding.

‍

Consortium composition

Unless otherwise provided for in the specific call conditions, only legal entities forming a consortium are eligible to participate in actions provided that the consortium includes, as beneficiaries, three legal entities independent from each other and each established in a different country as follows:

• at least one independent legal entity established in a Member State; and
• at least two other independent legal entities, each established in different Member States or Associated Countries.

‍

Budget

The total indicative budget for the topic is EUR 25.00 million.

The Commission estimates that an EU contribution of between EUR 4.00 and 8.00 million would allow these outcomes to be addressed appropriately.

‍